Jiangsu Trulive Medtech Co., Ltd.
PrivateLast Round
Series C
Nov 28, 2025
Total Funding Raised
$75.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jiangsu Trulive Medtech Co., Ltd. operates in Healthcare & Life Sciences and is based in Nantong. Its latest recorded funding round was a Series C round in November 2025.
Jiangsu Trulive Medtech Co., Ltd. is a cardiovascular intervention platform company that develops medical devices for heart valve, heart failure, peripheral, and coronary diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Trulive Medtech Co., Ltd. Comparables
Compare Jiangsu Trulive Medtech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Golden Stapler Surgical Co., Ltd. | 86% | |
| Zhejiang Geyi Medical Instrument Co., Ltd. | 86% | |
| EziSurg Medical | 86% |
For institutional investors. Book with your work email.
Jiangsu Trulive Medtech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 28, 2025 | ||||
| Series B | May 3, 2023 | ||||
| Series A | May 10, 2021 |
For institutional investors. Book with your work email.
Jiangsu Trulive Medtech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series A |
| Oriental Fortune Capital | Series C |
| Guoyuan Equity Investment | Series C |
| Proxima Ventures Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2025
$14M round led by Guoyuan Equity Investment and Oriental Fortune Capital.
- May 3, 2023
$14.3M round led by Proxima Ventures Ltd.
For institutional investors. Book with your work email.
Jiangsu Trulive Medtech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jiangsu Trulive Medtech Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Trulive Medtech Co., Ltd. a public or private company?
Jiangsu Trulive Medtech Co., Ltd. is a private company.
What is the current stock price of Jiangsu Trulive Medtech Co., Ltd.?
Jiangsu Trulive Medtech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Jiangsu Trulive Medtech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jiangsu Trulive Medtech Co., Ltd. worth (valuation)?
Valuation information for Jiangsu Trulive Medtech Co., Ltd. is not publicly available.
Can I buy Jiangsu Trulive Medtech Co., Ltd. stock?
Jiangsu Trulive Medtech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jiangsu Trulive Medtech Co., Ltd.'s last funding round?
Jiangsu Trulive Medtech Co., Ltd.'s most recent funding round was Series C on November 28, 2025.
Who are the main investors in Jiangsu Trulive Medtech Co., Ltd.?
Key investors in Jiangsu Trulive Medtech Co., Ltd. include Jifeng Ventures, Oriental Fortune Capital, Guoyuan Equity Investment.
Will Jiangsu Trulive Medtech Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu Trulive Medtech Co., Ltd..
How can I track Jiangsu Trulive Medtech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Jiangsu Trulive Medtech Co., Ltd.'s shares on secondary markets.